Register for our free email digests:
Boston Scientific Corp.
www.bostonscientific.com
Latest From Boston Scientific Corp.
TCT 2019: A Preview Of Late-Breaking Trials; Analyst Expectations
Interventional cardiologists can expect important updates on transcatheter valves and drug-eluting stents during this year's late-breaking trials presented at the annual Transcatheter Cardiovascular Therapeutics meeting next week. They include updates from Edwards Lifesciences, Medtronic, Boston Scientific and Abbott.
Exec Chat: ResMed's CEO Mick Farrell Outlines 2025 Strategy For 250 Million Users
ResMed's CEO Mick Farrell outlined the company's 2025 strategy: double-digit growth, drive up its user base to 250 million people and becoming the leading digital health company in both sleep apnea and chronic obstructive pulmonary (COPD) disease. Medtech Insight sat down with Farrell at ResMed's San Diego headquarters to learn more.
Pacts In Medtech: Audax Buys Hill-Rom’s Surgical Consumables; Boston Scientific To Distribute Endologix’s Products In China
Derived from Strategic Transactions, Informa's premium source for tracking life-sciences deals, the bimonthly Pacts In Medtech feature highlights notable technology alliances, research and development partnerships and commercial collaborations. This edition covers industry pacts that were signed in July and August 2019.
Continued Risks Of Duodenoscopes Leads FDA To Recommend Disposable Cap Devices
After a study earlier this year found that fixed endcap duodenoscopes continued to pose a significant risk of infecting patients after being washed, the US agency is now urging providers to switch to newer-designed scopes that reduce or eliminate the risk from reprocessing, such as duodenoscopes that have interchangeable caps. The directive from the FDA is good news for Boston Scientific, which makes a disposable duodenoscope that is close to being approved by the agency.
Company Information
- Industry
-
Medical Devices
- Implantable Devices
- Monitoring Equipment & Devices
- Rehabilitation Equipment and Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
- Therapeutic Areas
- Cancer
- Cardiovascular
- Gynecological, Urological
- Musculoskeletal & Connective Tissue Disorders
- Neurology, Nervous System
- Respiratory, Pulmonary
- Alias(es)
- Cardiovascular Imaging Systems (CVIS)
- Ownership
- Public
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
-
Boston Scientific Corp.
- Advanced Stent Technologies Inc.
- Apama Medical Inc.
- Asthmatx Inc.
- Atritech Inc.
- Augmenix Inc.
- Bard Electrophysiology
- BEI Medical Systems Co. Inc.
- Boston Scientific Japan KK
- BridgePoint Medical Inc.
- BTG PLC
- Cameron Health Inc.
- Cardiac Pathways Corp.
- CardioGene Therapeutics Inc.
- Cardiovascular Imaging Systems Inc.
- Catheter Innovations Inc.
- Claret Medical Inc.
- Corvita Corp.
- CryoCor Inc.
- CryoVascular Systems Inc.
- Embolic Protection Inc.
- EndoChoice Holdings Inc.
- EndoTex Interventional Systems Inc.
- Enteric Medical Technologies Inc.
- EP Technologies Inc.
- Guidant Corp.
- Heart Technology Inc.
- InFlow Dynamics Inc.
- IntElect Medical Inc.
- Interventional Technologies Inc.
- IoGyn Inc.
- Labcoat Ltd.
- Mansfield
- Mansfield EP
- Meadox Medicals Inc.
- Microvasive Inc.
- Millipede Inc.
- MinTec
- nVision Medical Corp.
- Possis Medical Inc.
- Precision Vascular Systems Inc.
- Quanam Medical Corp.
- RadioTherapeutics Corp.
- Remon Medical Technologies Ltd.
- ReVascular Therapeutics Inc.
- Rhythmia Medical Inc.
- Rubicon Medical Corp.
- Sadra Medical Inc.
- Schneider Worldwide
- SciMed Life Systems Inc.
- Securus Medical Group Inc.
- Smart Therapeutics Inc.
- Symbiosis Corp.
- Symetis SA
- Target Therapeutics Inc.
- Veniti Inc.
- VertiFlex Inc.
- Vesica Medical Inc.
- Vessix Vascular Inc.
- XLumena Inc.
- Senior Management
-
Michael F Mahoney, Chmn. & CEO
Daniel J Brennan, EVP, CFO
Ian Meredith, EVP, Global CMO
Edward Mackey, MD, PhD, EVP, Global Operations - Contact Info
-
Boston Scientific Corp.
Phone: (508) 683-4000
300 Boston Scientific Way
Marlborough, MA 01752-1234
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice